{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T19:36:40Z","timestamp":1790019400171,"version":"4.0.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82130024"],"award-info":[{"award-number":["82130024"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["T2341005"],"award-info":[{"award-number":["T2341005"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of Hunan Province","doi-asserted-by":"publisher","award":["2023JJ40809"],"award-info":[{"award-number":["2023JJ40809"]}],"id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Exp Mol Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>T cells contribute critically to obesity-induced adipose inflammation and insulin resistance, yet the co-stimulatory signals that govern their activation in adipose tissue remain unclear. Here, we systematically profile co-stimulatory molecules in adipocytes and adipose tissue macrophages and identify OX40 ligand (OX40L) as the most robustly upregulated in obesity. OX40L is also elevated in adipocytes from obese humans. Although macrophage-specific OX40L deletion has no metabolic impact, global OX40 deficiency or adipocyte-specific OX40L deletion reduces Th1 cell accumulation in visceral adipose tissue, attenuates inflammation and improves insulin sensitivity without affecting adiposity. These benefits are reversed by Th1 cell transfer. Therapeutic blockade of OX40L with a neutralizing antibody mimics the protective effects of genetic deletion. Our findings identify adipocyte-derived OX40L as a critical mediator of obesity-associated immune dysfunction and establish it as a targetable checkpoint for tissue-specific immunotherapy in metabolic disease.<\/jats:p>","DOI":"10.1038\/s12276-026-01770-8","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T04:24:26Z","timestamp":1783311866000},"page":"2293-2307","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Adipocyte OX40L promotes adipose T cell activation and insulin resistance in obesity"],"prefix":"10.1038","volume":"58","author":[{"given":"Jianfeng","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayi","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingpei","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujin","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanyu","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biling","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wuqian","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Mei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dandan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiang","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willa A.","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xian C.","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1770_CR1","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","volume":"403","author":"NCDRF Collaboration","year":"2024","unstructured":"Collaboration, N. C. D. R. F. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet 403, 1027\u20131050 (2024).","journal-title":"Lancet"},{"key":"1770_CR2","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1038\/s41574-019-0176-8","volume":"15","author":"M Bluher","year":"2019","unstructured":"Bluher, M. Obesity: global epidemiology and pathogenesis. Nat. Rev. Endocrinol. 15, 288\u2013298 (2019).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1770_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1172\/JCI92035","volume":"127","author":"AR Saltiel","year":"2017","unstructured":"Saltiel, A. R. & Olefsky, J. M. Inflammatory mechanisms linking obesity and metabolic disease. J. Clin. Invest. 127, 1\u20134 (2017).","journal-title":"J. Clin. Invest."},{"key":"1770_CR4","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1146\/annurev-pathol-012615-044359","volume":"11","author":"T Deng","year":"2016","unstructured":"Deng, T., Lyon, C. J., Bergin, S., Caligiuri, M. A. & Hsueh, W. A. Obesity, inflammation, and cancer. Annu Rev Pathol 11, 421\u2013449 (2016).","journal-title":"Annu Rev Pathol"},{"key":"1770_CR5","doi-asserted-by":"publisher","first-page":"1821","DOI":"10.1172\/JCI200319451","volume":"112","author":"H Xu","year":"2003","unstructured":"Xu, H. et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J. Clin. Invest. 112, 1821\u20131830 (2003).","journal-title":"J. Clin. Invest."},{"key":"1770_CR6","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1194\/jlr.M011338","volume":"52","author":"MM Altintas","year":"2011","unstructured":"Altintas, M. M. et al. Mast cells, macrophages, and crown-like structures distinguish subcutaneous from visceral fat in mice. J. Lipid Res. 52, 480\u2013488 (2011).","journal-title":"J. Lipid Res."},{"key":"1770_CR7","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1016\/j.cmet.2013.05.008","volume":"17","author":"D Mathis","year":"2013","unstructured":"Mathis, D. Immunological goings-on in visceral adipose tissue. Cell. Metab. 17, 851\u2013859 (2013).","journal-title":"Cell. Metab."},{"key":"1770_CR8","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1111\/dom.12154","volume":"15","author":"AW Ferrante Jr.","year":"2013","unstructured":"Ferrante, A. W. Jr. The immune cells in adipose tissue. Diabetes Obes. Metab. 15, 34\u201338 (2013).","journal-title":"Diabetes Obes. Metab."},{"key":"1770_CR9","doi-asserted-by":"publisher","first-page":"1796","DOI":"10.1172\/JCI200319246","volume":"112","author":"SP Weisberg","year":"2003","unstructured":"Weisberg, S. P. et al. Obesity is associated with macrophage accumulation in adipose tissue. J. Clin. Invest. 112, 1796\u20131808 (2003).","journal-title":"J. Clin. Invest."},{"key":"1770_CR10","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.immuni.2014.05.010","volume":"41","author":"JC McNelis","year":"2014","unstructured":"McNelis, J. C. & Olefsky, J. M. Macrophages, immunity, and metabolic disease. Immunity 41, 36\u201348 (2014).","journal-title":"Immunity"},{"key":"1770_CR11","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1016\/j.cell.2019.05.054","volume":"178","author":"DA Jaitin","year":"2019","unstructured":"Jaitin, D. A. et al. Lipid-associated macrophages control metabolic homeostasis in a Trem2-dependent manner. Cell 178, 686\u2013698.e14 (2019).","journal-title":"Cell"},{"key":"1770_CR12","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1038\/nm.2002","volume":"15","author":"M Feuerer","year":"2009","unstructured":"Feuerer, M. et al. Lean, but not obese, fat is enriched for a unique population of regulatory T cells that affect metabolic parameters. Nat. Med. 15, 930\u2013939 (2009).","journal-title":"Nat. Med."},{"key":"1770_CR13","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1111\/imr.13354","volume":"324","author":"Y Valentine","year":"2024","unstructured":"Valentine, Y. & Nikolajczyk, B. S. T cells in obesity-associated inflammation: the devil is in the details. Immunol. Rev. 324, 25\u201341 (2024).","journal-title":"Immunol. Rev."},{"key":"1770_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1038\/s41574-023-00908-2","volume":"20","author":"RD Jacks","year":"2024","unstructured":"Jacks, R. D. & Lumeng, C. N. Macrophage and T cell networks in adipose tissue. Nat. Rev. Endocrinol. 20, 50\u201361 (2024).","journal-title":"Nat. Rev. Endocrinol."},{"key":"1770_CR15","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1016\/j.cmet.2013.02.019","volume":"17","author":"E Stolarczyk","year":"2013","unstructured":"Stolarczyk, E. et al. Improved insulin sensitivity despite increased visceral adiposity in mice deficient for the immune cell transcription factor T-bet. Cell Metab. 17, 520\u2013533 (2013).","journal-title":"Cell Metab."},{"key":"1770_CR16","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1038\/nm.1964","volume":"15","author":"S Nishimura","year":"2009","unstructured":"Nishimura, S. et al. CD8+ effector T cells contribute to macrophage recruitment and adipose tissue inflammation in obesity. Nat. Med. 15, 914\u2013920 (2009).","journal-title":"Nat. Med."},{"key":"1770_CR17","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1038\/nri3405","volume":"13","author":"L Chen","year":"2013","unstructured":"Chen, L. & Flies, D. B. Molecular mechanisms of T cell co-stimulation and co-inhibition. Nat. Rev. Immunol. 13, 227\u2013242 (2013).","journal-title":"Nat. Rev. Immunol."},{"key":"1770_CR18","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.cmet.2013.02.009","volume":"17","author":"T Deng","year":"2013","unstructured":"Deng, T. et al. Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation. Cell Metab. 17, 411\u2013422 (2013).","journal-title":"Cell Metab."},{"key":"1770_CR19","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15725","volume":"8","author":"T Deng","year":"2017","unstructured":"Deng, T., Liu, J., Deng, Y., Minze, L. & Hsueh, W. A. Adipocyte adaptive immunity mediates diet-induced adipose inflammation and insulin resistance by decreasing adipose Treg cells. Nat. Commun. 8, 15725 (2017).","journal-title":"Nat. Commun."},{"key":"1770_CR20","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1016\/j.celrep.2014.09.004","volume":"9","author":"KW Cho","year":"2014","unstructured":"Cho, K. W. et al. An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation. Cell Rep. 9, 605\u2013617 (2014).","journal-title":"Cell Rep."},{"key":"1770_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15725","volume":"8","author":"T Deng","year":"2017","unstructured":"Deng, T. et al. Adipocyte adaptive immunity mediates diet-induced adipose inflammation and insulin resistance by decreasing adipose Treg cells. Nat. Commun. 8, 15725 (2017).","journal-title":"Nat. Commun."},{"key":"1770_CR22","doi-asserted-by":"publisher","first-page":"1196","DOI":"10.1002\/hep.27233","volume":"60","author":"A Chatzigeorgiou","year":"2014","unstructured":"Chatzigeorgiou, A. et al. Dual role of B7 costimulation in obesity-related nonalcoholic steatohepatitis and metabolic dysregulation. Hepatology 60, 1196\u20131210 (2014).","journal-title":"Hepatology"},{"key":"1770_CR23","doi-asserted-by":"publisher","first-page":"2414","DOI":"10.1161\/CIRCULATIONAHA.113.008055","volume":"129","author":"D Wolf","year":"2014","unstructured":"Wolf, D. et al. Coinhibitory suppression of T cell activation by CD40 protects against obesity and adipose tissue inflammation in mice. Circulation 129, 2414\u20132425 (2014).","journal-title":"Circulation"},{"key":"1770_CR24","doi-asserted-by":"publisher","first-page":"2751","DOI":"10.2337\/db13-1657","volume":"63","author":"Z Yi","year":"2014","unstructured":"Yi, Z., Stunz, L. L. & Bishop, G. A. CD40-mediated maintenance of immune homeostasis in the adipose tissue microenvironment. Diabetes 63, 2751\u20132760 (2014).","journal-title":"Diabetes"},{"key":"1770_CR25","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2337\/db13-1094","volume":"63","author":"J Zhong","year":"2014","unstructured":"Zhong, J. et al. T-cell costimulation protects obesity-induced adipose inflammation and insulin resistance. Diabetes 63, 1289\u20131302 (2014).","journal-title":"Diabetes"},{"key":"1770_CR26","doi-asserted-by":"publisher","first-page":"3159","DOI":"10.2337\/db10-1805","volume":"60","author":"CS Kim","year":"2011","unstructured":"Kim, C. S. et al. Deficiency for costimulatory receptor 4-1BB protects against obesity-induced inflammation and metabolic disorders. Diabetes 60, 3159\u20133168 (2011).","journal-title":"Diabetes"},{"key":"1770_CR27","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20201142","volume":"218","author":"KL Mittelsteadt","year":"2021","unstructured":"Mittelsteadt, K. L., Hayes, E. T. & Campbell, D. J. ICOS signaling limits regulatory T cell accumulation and function in visceral adipose tissue. J. Exp. Med. 218, e20201142 (2021).","journal-title":"J. Exp. Med."},{"key":"1770_CR28","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1038\/s41586-022-04518-2","volume":"603","author":"MP Emont","year":"2022","unstructured":"Emont, M. P. et al. A single-cell atlas of human and mouse white adipose tissue. Nature 603, 926\u2013933 (2022).","journal-title":"Nature"},{"key":"1770_CR29","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1161\/CIRCRESAHA.108.177105","volume":"103","author":"VZ Rocha","year":"2008","unstructured":"Rocha, V. Z. et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ. Res. 103, 467\u2013476 (2008).","journal-title":"Circ. Res."},{"key":"1770_CR30","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1016\/j.cell.2012.02.017","volume":"148","author":"VT Samuel","year":"2012","unstructured":"Samuel, V. T. & Shulman, G. I. Mechanisms for insulin resistance: common threads and missing links. Cell 148, 852\u2013871 (2012).","journal-title":"Cell"},{"key":"1770_CR31","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1006\/bbrc.1998.8199","volume":"244","author":"M Yamaguchi","year":"1998","unstructured":"Yamaguchi, M. et al. Autocrine inhibition of leptin production by tumor necrosis factor-\u03b1 (TNF-\u03b1) through TNF-\u03b1 type-I receptor in vitro. Biochem. Biophys. Res. Commun. 244, 30\u201334 (1998).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1770_CR32","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.tem.2012.05.011","volume":"23","author":"HS Schipper","year":"2012","unstructured":"Schipper, H. S., Prakken, B., Kalkhoven, E. & Boes, M. Adipose tissue-resident immune cells: key players in immunometabolism. Trends Endocrinol. Metab. 23, 407\u2013415 (2012).","journal-title":"Trends Endocrinol. Metab."},{"key":"1770_CR33","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev-physiol-042222-024353","volume":"86","author":"D Bradley","year":"2024","unstructured":"Bradley, D., Deng, T., Shantaram, D. & Hsueh, W. A. Orchestration of the adipose tissue immune landscape by adipocytes. Annu. Rev. Physiol. 86, 199\u2013223 (2024).","journal-title":"Annu. Rev. Physiol."},{"key":"1770_CR34","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1161\/ATVBAHA.109.192583","volume":"29","author":"C Duffaut","year":"2009","unstructured":"Duffaut, C. et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler. Thromb. Vasc. Biol. 29, 1608\u20131614 (2009).","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"1770_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1038\/29795","volume":"394","author":"GM Lord","year":"1998","unstructured":"Lord, G. M. et al. Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression. Nature 394, 897\u2013901 (1998).","journal-title":"Nature"},{"key":"1770_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/nri1350","volume":"4","author":"A La Cava","year":"2004","unstructured":"La Cava, A. & Matarese, G. The weight of leptin in immunity. Nat. Rev. Immunol. 4, 371\u2013379 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"1770_CR37","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113963","volume":"43","author":"X Liao","year":"2024","unstructured":"Liao, X. et al. Adipose stem cells control obesity-induced T cell infiltration into adipose tissue. Cell Rep. 43, 113963 (2024).","journal-title":"Cell Rep."},{"key":"1770_CR38","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1038\/s41573-020-0081-9","volume":"19","author":"NM Edner","year":"2020","unstructured":"Edner, N. M., Carlesso, G., Rush, J. S. & Walker, L. S. K. Targeting co-stimulatory molecules in autoimmune disease. Nat. Rev. Drug Discov. 19, 860\u2013883 (2020).","journal-title":"Nat. Rev. Drug Discov."},{"key":"1770_CR39","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1111\/j.1365-2222.2005.02369.x","volume":"35","author":"T Kallinich","year":"2005","unstructured":"Kallinich, T., Beier, K. C., Gelfand, E. W., Kroczek, R. A. & Hamelmann, E. Co-stimulatory molecules as potential targets for therapeutic intervention in allergic airway disease. Clin. Exp. Allergy 35, 1521\u20131534 (2005).","journal-title":"Clin. Exp. Allergy"},{"key":"1770_CR40","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1038\/s41577-024-01061-1","volume":"24","author":"MT Lotze","year":"2024","unstructured":"Lotze, M. T., Olejniczak, S. H. & Skokos, D. CD28 co-stimulation: novel insights and applications in cancer immunotherapy. Nat. Rev. Immunol. 24, 878\u2013895 (2024).","journal-title":"Nat. Rev. Immunol."},{"key":"1770_CR41","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1084\/jem.165.2.302","volume":"165","author":"MK Jenkins","year":"1987","unstructured":"Jenkins, M. K. & Schwartz, R. H. Antigen presentation by chemically modified splenocytes induces antigen-specific T cell unresponsiveness in vitro and in vivo. J. Exp. Med. 165, 302\u2013319 (1987).","journal-title":"J. Exp. Med."},{"key":"1770_CR42","doi-asserted-by":"publisher","first-page":"2617","DOI":"10.4049\/jimmunol.142.8.2617","volume":"142","author":"DL Mueller","year":"1989","unstructured":"Mueller, D. L., Jenkins, M. K. & Schwartz, R. H. An accessory cell-derived costimulatory signal acts independently of protein kinase C activation to allow T cell proliferation and prevent the induction of unresponsiveness. J. Immunol. 142, 2617\u20132628 (1989).","journal-title":"J. Immunol."},{"key":"1770_CR43","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22168666","volume":"22","author":"S Soedono","year":"2021","unstructured":"Soedono, S. & Cho, K. W. Adipose tissue dendritic cells: critical regulators of obesity-induced inflammation and insulin resistance. Int. J. Mol. Sci. 22, 8666. (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1770_CR44","doi-asserted-by":"publisher","first-page":"3650","DOI":"10.4049\/jimmunol.1600820","volume":"197","author":"KW Cho","year":"2016","unstructured":"Cho, K. W. et al. Adipose tissue dendritic cells are independent contributors to obesity-induced inflammation and insulin resistance. J. Immunol. 197, 3650\u20133661 (2016).","journal-title":"J. Immunol."},{"key":"1770_CR45","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.apsb.2019.08.010","volume":"10","author":"Y Fu","year":"2020","unstructured":"Fu, Y., Lin, Q., Zhang, Z. & Zhang, L. Therapeutic strategies for the costimulatory molecule OX40 in T-cell-mediated immunity. Acta Pharm. Sin. B. 10, 414\u2013433 (2020).","journal-title":"Acta Pharm. Sin. B."},{"key":"1770_CR46","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1002\/jnr.490430105","volume":"43","author":"AD Weinberg","year":"1996","unstructured":"Weinberg, A. D. et al. OX-40 antibody enhances for autoantigen specific V\u03b28.2+ T cells within the spinal cord of Lewis rats with autoimmune encephalomyelitis. J. Neurosci. Res. 43, 42\u201349 (1996).","journal-title":"J. Neurosci. Res."},{"key":"1770_CR47","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.4049\/jimmunol.166.3.2108","volume":"166","author":"C Nohara","year":"2001","unstructured":"Nohara, C. et al. Amelioration of experimental autoimmune encephalomyelitis with anti-OX40 ligand monoclonal antibody: a critical role for OX40 ligand in migration, but not development, of pathogenic T cells. J. Immunol. 166, 2108\u20132115 (2001).","journal-title":"J. Immunol."},{"key":"1770_CR48","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1089\/hyb.2007.010","volume":"26","author":"M Li","year":"2007","unstructured":"Li, M., Yang, Q. & Zhang, Y. Effects of CD134 monoclonal antibody on hemolysis activities and expression of perforin in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Hybridoma 26, 191\u2013200 (2007).","journal-title":"Hybridoma"},{"key":"1770_CR49","doi-asserted-by":"publisher","DOI":"10.1186\/s13075-017-1261-9","volume":"19","author":"J Jiang","year":"2017","unstructured":"Jiang, J. et al. OX40 signaling is involved in the autoactivation of CD4+CD28\u2212 T cells and contributes to the pathogenesis of autoimmune arthritis. Arthritis Res. Ther. 19, 67 (2017).","journal-title":"Arthritis Res. Ther."},{"key":"1770_CR50","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1002\/1521-4141(200010)30:10<2815::AID-IMMU2815>3.0.CO;2-#","volume":"30","author":"T Yoshioka","year":"2000","unstructured":"Yoshioka, T. et al. Contribution of OX40\/OX40 ligand interaction to the pathogenesis of rheumatoid arthritis. Eur. J. Immunol. 30, 2815\u20132823 (2000).","journal-title":"Eur. J. Immunol."},{"key":"1770_CR51","doi-asserted-by":"publisher","first-page":"3265","DOI":"10.1002\/eji.200324124","volume":"33","author":"F Obermeier","year":"2003","unstructured":"Obermeier, F. et al. OX40\/OX40L interaction induces the expression of CXCR5 and contributes to chronic colitis induced by dextran sulfate sodium in mice. Eur. J. Immunol. 33, 3265\u20133274 (2003).","journal-title":"Eur. J. Immunol."},{"key":"1770_CR52","doi-asserted-by":"publisher","first-page":"G595","DOI":"10.1152\/ajpgi.00450.2002","volume":"284","author":"T Totsuka","year":"2003","unstructured":"Totsuka, T. et al. Therapeutic effect of anti-OX40L and anti-TNF-\u03b1 MAbs in a murine model of chronic colitis. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G595\u2013G603 (2003).","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"1770_CR53","doi-asserted-by":"publisher","first-page":"6972","DOI":"10.4049\/jimmunol.166.11.6972","volume":"166","author":"V Malmstrom","year":"2001","unstructured":"Malmstrom, V. et al. CD134L expression on dendritic cells in the mesenteric lymph nodes drives colitis in T cell-restored SCID mice. J. Immunol. 166, 6972\u20136981 (2001).","journal-title":"J. Immunol."},{"key":"1770_CR54","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1016\/j.jaci.2018.11.053","volume":"144","author":"E Guttman-Yassky","year":"2019","unstructured":"Guttman-Yassky, E. et al. GBR 830, an anti-OX40, improves skin gene signatures and clinical scores in patients with atopic dermatitis. J. Allergy Clin. Immunol. 144, 482\u2013493.e7 (2019).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1770_CR55","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1089\/derm.2024.0058","volume":"36","author":"N Schettini","year":"2025","unstructured":"Schettini, N., Pacetti, L., Corazza, M. & Borghi, A. The role of OX40-OX40L axis in the pathogenesis of atopic dermatitis. Dermatitis 36, 28\u201336 (2025).","journal-title":"Dermatitis"},{"key":"1770_CR56","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1016\/j.jaci.2024.10.031","volume":"155","author":"S Weidinger","year":"2025","unstructured":"Weidinger, S. et al. Phase 2b randomized clinical trial of amlitelimab, an anti-OX40 ligand antibody, in patients with moderate-to-severe atopic dermatitis. J. Allergy Clin. Immunol. 155, 1264\u20131275 (2025).","journal-title":"J. Allergy Clin. Immunol."},{"key":"1770_CR57","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/S0140-6736(22)02037-2","volume":"401","author":"E Guttman-Yassky","year":"2023","unstructured":"Guttman-Yassky, E. et al. An anti-OX40 antibody to treat moderate-to-severe atopic dermatitis: a multicentre, double-blind, placebo-controlled phase 2b study. Lancet 401, 204\u2013214 (2023).","journal-title":"Lancet"},{"key":"1770_CR58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1093\/bjd\/ljad240","volume":"189","author":"S Weidinger","year":"2023","unstructured":"Weidinger, S. et al. Safety and efficacy of amlitelimab, a fully human nondepleting, noncytotoxic anti-OX40 ligand monoclonal antibody, in atopic dermatitis: results of a phase IIa randomized placebo-controlled trial. Br. J. Dermatol. 189, 531\u2013539 (2023).","journal-title":"Br. J. Dermatol."},{"key":"1770_CR59","doi-asserted-by":"publisher","first-page":"3827","DOI":"10.1007\/s00018-017-2552-7","volume":"74","author":"B Liu","year":"2017","unstructured":"Liu, B. et al. OX40 promotes obesity-induced adipose inflammation and insulin resistance. Cell Mol. Life Sci. 74, 3827\u20133840 (2017).","journal-title":"Cell Mol. Life Sci."}],"container-title":["Experimental &amp; Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01770-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01770-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01770-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T04:09:03Z","timestamp":1785816543000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s12276-026-01770-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":59,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2026,7]]}},"alternative-id":["1770"],"URL":"https:\/\/doi.org\/10.1038\/s12276-026-01770-8","relation":{},"ISSN":["2092-6413"],"issn-type":[{"value":"2092-6413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"7 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 March 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 April 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}